PIROZZI, FLORA
 Distribuzione geografica
Continente #
NA - Nord America 380
EU - Europa 177
AS - Asia 93
Totale 650
Nazione #
US - Stati Uniti d'America 374
IT - Italia 96
CN - Cina 67
UA - Ucraina 34
VN - Vietnam 22
IE - Irlanda 13
FI - Finlandia 10
FR - Francia 9
SE - Svezia 7
CA - Canada 6
KR - Corea 4
GB - Regno Unito 3
SK - Slovacchia (Repubblica Slovacca) 3
RU - Federazione Russa 2
Totale 650
Città #
Chandler 166
Beijing 22
Dong Ket 22
Millbury 22
Napoli 22
Des Moines 18
Nanjing 17
Princeton 17
Boston 15
Lawrence 13
Wilmington 12
Nanchang 7
Woodbridge 6
Ashburn 4
Changsha 4
Dearborn 4
Piemonte 4
Shenyang 4
Augusta 3
Boardman 3
Chengdu 3
Houston 3
Jiaxing 3
Kosice 3
Ottawa 3
Redwood City 3
Seattle 3
Seoul 3
Fairfield 2
Guangzhou 2
Hebei 2
Marcianise 2
Montichiari 2
Norwalk 2
Oliveto Citra 2
Rome 2
Salerno 2
San Mateo 2
Torre Annunziata 2
Angri 1
Ann Arbor 1
Ariano Irpino 1
Brindisi 1
Caserta 1
Cava 1
Corleto Perticara 1
Florence 1
Fontenay-aux-roses 1
Fremont 1
Kunming 1
Leawood 1
Malo 1
Monmouth Junction 1
Montesarchio 1
Mugnano Di Napoli 1
Naples 1
New York 1
Palma Campania 1
Perugia 1
Piazzola Sul Brenta 1
Piove Di Sacco 1
Pozzuoli 1
Roccapiemonte 1
Saluzzo 1
San Giorgio Del Sannio 1
San Martino Valle Caudina 1
Savannah 1
Shanghai 1
Sunnyvale 1
Taizhou 1
Toronto 1
Tramonti 1
Turin 1
Yellow Springs 1
Totale 466
Nome #
Chiusura transcatetere percutanea di un difetto interatriale tipo forame ovale guidata con ecocardiografia intracardiaca in una paziente anziana 55
Antineoplastic drug-induced cardiotoxicity: A redox perspective 46
Nanotechnology-Based Cardiac Targeting and Direct Cardiac Reprogramming: The Betrothed 44
Hemodialysis does not affect ventricular-arterial coupling beyond the reduction of blood pressure and preload. 36
What is the cardiac impact of chemotherapy and subsequent radiotherapy in lymphoma patients 33
Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes 32
Mitral peak early diastolic filling velocity to deceleration time ratio as a predictor of prognosis in patients with chronic heart failure and preserved or reduced ejection fraction. 31
Autophagy and cancer therapy cardiotoxicity: From molecular mechanisms to therapeutic opportunities 30
Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs 27
Biomarkers in sarcopenia: A multifactorial approach. 27
Phosphoinositide 3-Kinase Gamma Inhibition Protects from Anthracycline Cardiotoxicity and Reduces Tumor Growth 26
Statins in cardiovascular prevention in the oldest-old. A black hole 26
Low-intensity pulsed ultrasound (LIPUS) in heart failure with preserved ejection fraction (HFpEF): lupus in fabula? 26
A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled trial 25
Depression and chronic heart failure in the elderly: An intriguing relationship 25
Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions—A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of Cardiology 24
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors 24
Arterial Wave Reflections and Ventricular-Vascular Interaction in Patients With Left Ventricular Systolic Dysfunction. 21
Hemodialysis does not affect ventricular-arterial coupling beyond the reduction of blood pressure and preload. 21
Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment 20
Systemic capillary leak syndrome or Clarkson's disease: A case report 19
How can we manage the cardiac toxicity of immune checkpoint inhibitors? 18
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases 17
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications 15
New-Onset Cancer in the HF Population: Epidemiology, Pathophysiology, and Clinical Management 15
Prevention of cancer-therapy-related heart failure 14
Oxidative stress in anticancer therapies-related cardiac dysfunction 13
Review and metaanalysis of the frequency of familial dilated cardiomyopathy. 12
Chatting Second Messengers: PIP3 and cAMP 12
PI3K signaling in chronic obstructive pulmonary disease: mechanisms, targets, and therapy 6
Totale 740
Categoria #
all - tutte 1455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1455


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201819 0000 00 02 14300
2018/201935 6025 21 47 4013
2019/2020113 40035 410 67 082010
2020/2021121 6625 58 198 1019726
2021/2022197 81412 48 710 15214859
2022/2023204 33301335 4238 013 0000
Totale 740